Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-077684
Filing Date
2025-08-18
Accepted
2025-08-18 06:12:36
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0253157-10q_klotho.htm   iXBRL 10-Q 649740
2 CERTIFICATION ea025315701ex31-1_klotho.htm EX-31.1 10698
3 CERTIFICATION ea025315701ex31-2_klotho.htm EX-31.2 10701
4 CERTIFICATION ea025315701ex32-1_klotho.htm EX-32.1 4062
5 CERTIFICATION ea025315701ex32-2_klotho.htm EX-32.2 4015
  Complete submission text file 0001213900-25-077684.txt   5181374

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE klto-20250630.xsd EX-101.SCH 52161
7 XBRL CALCULATION FILE klto-20250630_cal.xml EX-101.CAL 30154
8 XBRL DEFINITION FILE klto-20250630_def.xml EX-101.DEF 276346
9 XBRL LABEL FILE klto-20250630_lab.xml EX-101.LAB 452059
10 XBRL PRESENTATION FILE klto-20250630_pre.xml EX-101.PRE 281379
65 EXTRACTED XBRL INSTANCE DOCUMENT ea0253157-10q_klotho_htm.xml XML 535388
Mailing Address 13576 WALNUT STREET, SUITE A OMAHA NE 68144
Business Address 13576 WALNUT STREET, SUITE A OMAHA NE 68144 (833) 931-6330
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41340 | Film No.: 251226215
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)